AptarGroup, Inc. (NYSE: ATR) Stock Competitors & Peer Comparison
See ATR's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ATR and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ATR | $126.55 | -1.21% | 8B | 22.13 | $5.72 | +1.52% |
| ISRG | $452.29 | +1.90% | 159.8B | 47.02 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +1.99% |
| BDX | $198.91 | -0.75% | 54.2B | 15.30 | $13.00 | +1.99% |
| RMD | $252.86 | -0.08% | 35.5B | 23.47 | $10.77 | +0.97% |
| MDLN | $34.09 | -2.26% | 29.9B | 24.98 | $1.36 | N/A |
| WST | $392.15 | -0.48% | 27.6B | 46.12 | $8.50 | +0.22% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $85.41 | -2.33% | 14.5B | 12.03 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +1.99% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
ATR vs ISRG Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, ISRG has a market cap of 159.8B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while ISRG trades at $452.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas ISRG's P/E ratio is 47.02. In terms of profitability, ATR's ROE is +0.14%, compared to ISRG's ROE of +0.17%. Regarding short-term risk, ATR is less volatile compared to ISRG. This indicates lower risk in terms of short-term price fluctuations for ATR.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
ATR vs BDXA Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas BDXA's P/E ratio is 45.70. In terms of profitability, ATR's ROE is +0.14%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, ATR is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for ATR.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
ATR vs BDX Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, BDX has a market cap of 54.2B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while BDX trades at $198.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas BDX's P/E ratio is 15.30. In terms of profitability, ATR's ROE is +0.14%, compared to BDX's ROE of +0.04%. Regarding short-term risk, ATR is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for ATR.Check BDX's competition here
ResMed Inc. (NYSE: RMD)
ATR vs RMD Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, RMD has a market cap of 35.5B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while RMD trades at $252.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas RMD's P/E ratio is 23.47. In terms of profitability, ATR's ROE is +0.14%, compared to RMD's ROE of +0.24%. Regarding short-term risk, ATR is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for ATR.Check RMD's competition here
Medline Inc. (NASDAQ: MDLN)
ATR vs MDLN Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, MDLN has a market cap of 29.9B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while MDLN trades at $34.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas MDLN's P/E ratio is 24.98. In terms of profitability, ATR's ROE is +0.14%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, ATR is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for ATR.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
ATR vs WST Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, WST has a market cap of 27.6B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while WST trades at $392.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas WST's P/E ratio is 46.12. In terms of profitability, ATR's ROE is +0.14%, compared to WST's ROE of +0.19%. Regarding short-term risk, ATR is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for ATR.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
ATR vs HOLX Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas HOLX's P/E ratio is 31.54. In terms of profitability, ATR's ROE is +0.14%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, ATR is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for ATR.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
ATR vs SOLV Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, SOLV has a market cap of 14.5B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while SOLV trades at $85.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas SOLV's P/E ratio is 12.03. In terms of profitability, ATR's ROE is +0.14%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, ATR is less volatile compared to SOLV. This indicates lower risk in terms of short-term price fluctuations for ATR.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
ATR vs BDXB Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas BDXB's P/E ratio is 7.60. In terms of profitability, ATR's ROE is +0.14%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, ATR is less volatile compared to BDXB. This indicates lower risk in terms of short-term price fluctuations for ATR.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
ATR vs BAX Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, BAX has a market cap of 13.1B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while BAX trades at $25.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas BAX's P/E ratio is 12.17. In terms of profitability, ATR's ROE is +0.14%, compared to BAX's ROE of -0.17%. Regarding short-term risk, ATR is less volatile compared to BAX. This indicates lower risk in terms of short-term price fluctuations for ATR.Check BAX's competition here
Avantor, Inc. (NYSE: AVTR)
ATR vs AVTR Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, AVTR has a market cap of 11.7B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while AVTR trades at $17.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas AVTR's P/E ratio is 20.34. In terms of profitability, ATR's ROE is +0.14%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, ATR is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for ATR.Check AVTR's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
ATR vs COO Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, COO has a market cap of 11.6B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while COO trades at $61.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas COO's P/E ratio is 13.42. In terms of profitability, ATR's ROE is +0.14%, compared to COO's ROE of +0.07%. Regarding short-term risk, ATR is less volatile compared to COO. This indicates lower risk in terms of short-term price fluctuations for ATR.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
ATR vs RGEN Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, RGEN has a market cap of 11.2B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while RGEN trades at $176.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas RGEN's P/E ratio is 98.29. In terms of profitability, ATR's ROE is +0.14%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, ATR is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for ATR.Check RGEN's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
ATR vs BLCO Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, BLCO has a market cap of 6.2B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while BLCO trades at $17.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas BLCO's P/E ratio is 26.86. In terms of profitability, ATR's ROE is +0.14%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, ATR is less volatile compared to BLCO. This indicates lower risk in terms of short-term price fluctuations for ATR.Check BLCO's competition here
Teleflex Incorporated (NYSE: TFX)
ATR vs TFX Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, TFX has a market cap of 5.8B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while TFX trades at $136.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas TFX's P/E ratio is 15.58. In terms of profitability, ATR's ROE is +0.14%, compared to TFX's ROE of -0.32%. Regarding short-term risk, ATR is less volatile compared to TFX. This indicates lower risk in terms of short-term price fluctuations for ATR.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
ATR vs MMSI Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, MMSI has a market cap of 5.6B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while MMSI trades at $93.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas MMSI's P/E ratio is 23.86. In terms of profitability, ATR's ROE is +0.14%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, ATR is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for ATR.Check MMSI's competition here
Stevanato Group S.p.A. (NYSE: STVN)
ATR vs STVN Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, STVN has a market cap of 5.3B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while STVN trades at $19.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas STVN's P/E ratio is 29.58. In terms of profitability, ATR's ROE is +0.14%, compared to STVN's ROE of +0.09%. Regarding short-term risk, ATR is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for ATR.Check STVN's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
ATR vs ICUI Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, ICUI has a market cap of 4.2B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while ICUI trades at $166.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas ICUI's P/E ratio is 20.80. In terms of profitability, ATR's ROE is +0.14%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, ATR is less volatile compared to ICUI. This indicates lower risk in terms of short-term price fluctuations for ATR.Check ICUI's competition here
Envista Holdings Corp (NYSE: NVST)
ATR vs NVST Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, NVST has a market cap of 3.8B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while NVST trades at $23.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas NVST's P/E ratio is 16.04. In terms of profitability, ATR's ROE is +0.14%, compared to NVST's ROE of +0.03%. Regarding short-term risk, ATR is less volatile compared to NVST. This indicates lower risk in terms of short-term price fluctuations for ATR.Check NVST's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
ATR vs PLSE Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, PLSE has a market cap of 3.8B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while PLSE trades at $53.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas PLSE's P/E ratio is -44.64. In terms of profitability, ATR's ROE is +0.14%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, ATR is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for ATR.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
ATR vs ATRC Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, ATRC has a market cap of 3B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while ATRC trades at $58.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas ATRC's P/E ratio is 1831.37. In terms of profitability, ATR's ROE is +0.14%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, ATR is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for ATR.Check ATRC's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
ATR vs LMAT Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while LMAT trades at $84.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas LMAT's P/E ratio is 31.05. In terms of profitability, ATR's ROE is +0.14%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, ATR is similarly volatile compared to LMAT. This indicates similar risk in terms of short-term price fluctuations for ATR.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
ATR vs BLFS Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, BLFS has a market cap of 1.9B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while BLFS trades at $38.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas BLFS's P/E ratio is 37.49. In terms of profitability, ATR's ROE is +0.14%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, ATR is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for ATR.Check BLFS's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
ATR vs XRAY Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, XRAY has a market cap of 1.9B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while XRAY trades at $9.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas XRAY's P/E ratio is 6.59. In terms of profitability, ATR's ROE is +0.14%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, ATR is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for ATR.Check XRAY's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
ATR vs KMTS Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, KMTS has a market cap of 1.7B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while KMTS trades at $28.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas KMTS's P/E ratio is -10.85. In terms of profitability, ATR's ROE is +0.14%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, ATR is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for ATR.Check KMTS's competition here
Azenta, Inc. (NASDAQ: AZTA)
ATR vs AZTA Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, AZTA has a market cap of 1.6B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while AZTA trades at $36.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas AZTA's P/E ratio is 86.90. In terms of profitability, ATR's ROE is +0.14%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, ATR is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for ATR.Check AZTA's competition here
STAAR Surgical Company (NASDAQ: STAA)
ATR vs STAA Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, STAA has a market cap of 1.1B. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while STAA trades at $22.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas STAA's P/E ratio is 39.67. In terms of profitability, ATR's ROE is +0.14%, compared to STAA's ROE of +0.01%. Regarding short-term risk, ATR is similarly volatile compared to STAA. This indicates similar risk in terms of short-term price fluctuations for ATR.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
ATR vs ATRI Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas ATRI's P/E ratio is 64.50. In terms of profitability, ATR's ROE is +0.14%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, ATR is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for ATR.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
ATR vs ANGO Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, ANGO has a market cap of 520M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while ANGO trades at $12.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas ANGO's P/E ratio is -31.71. In terms of profitability, ATR's ROE is +0.14%, compared to ANGO's ROE of -0.19%. Regarding short-term risk, ATR is less volatile compared to ANGO. This indicates lower risk in terms of short-term price fluctuations for ATR.Check ANGO's competition here
MiniMed Group, Inc. (NASDAQ: MMEDV)
ATR vs MMEDV Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, MMEDV has a market cap of 495.6M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while MMEDV trades at $17.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas MMEDV's P/E ratio is N/A. In terms of profitability, ATR's ROE is +0.14%, compared to MMEDV's ROE of N/A. Regarding short-term risk, ATR is less volatile compared to MMEDV. This indicates lower risk in terms of short-term price fluctuations for ATR.Check MMEDV's competition here
Embecta Corp. (NASDAQ: EMBC)
ATR vs EMBC Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, EMBC has a market cap of 380.2M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while EMBC trades at $6.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas EMBC's P/E ratio is 2.58. In terms of profitability, ATR's ROE is +0.14%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, ATR is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for ATR.Check EMBC's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
ATR vs SMTI Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, SMTI has a market cap of 301.4M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while SMTI trades at $32.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas SMTI's P/E ratio is -546.67. In terms of profitability, ATR's ROE is +0.14%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, ATR is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for ATR.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
ATR vs OSUR Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, OSUR has a market cap of 284.8M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while OSUR trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas OSUR's P/E ratio is -5.99. In terms of profitability, ATR's ROE is +0.14%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, ATR is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for ATR.Check OSUR's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
ATR vs UTMD Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, UTMD has a market cap of 235.6M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while UTMD trades at $74.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas UTMD's P/E ratio is 21.96. In terms of profitability, ATR's ROE is +0.14%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, ATR is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for ATR.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
ATR vs PDEX Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, PDEX has a market cap of 201.2M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while PDEX trades at $62.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas PDEX's P/E ratio is 15.07. In terms of profitability, ATR's ROE is +0.14%, compared to PDEX's ROE of +0.31%. Regarding short-term risk, ATR is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for ATR.Check PDEX's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
ATR vs NNNN Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, NNNN has a market cap of 167.2M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while NNNN trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas NNNN's P/E ratio is 25.40. In terms of profitability, ATR's ROE is +0.14%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, ATR is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for ATR.Check NNNN's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
ATR vs KRMD Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, KRMD has a market cap of 145.6M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while KRMD trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas KRMD's P/E ratio is -79.25. In terms of profitability, ATR's ROE is +0.14%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, ATR is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for ATR.Check KRMD's competition here
Stereotaxis, Inc. (AMEX: STXS)
ATR vs STXS Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, STXS has a market cap of 101.2M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while STXS trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas STXS's P/E ratio is -5.94. In terms of profitability, ATR's ROE is +0.14%, compared to STXS's ROE of -1.33%. Regarding short-term risk, ATR is less volatile compared to STXS. This indicates lower risk in terms of short-term price fluctuations for ATR.Check STXS's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
ATR vs AKYA Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas AKYA's P/E ratio is -1.34. In terms of profitability, ATR's ROE is +0.14%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, ATR is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for ATR.Check AKYA's competition here
SkyAI, Inc. (NASDAQ: STSS)
ATR vs STSS Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas STSS's P/E ratio is -0.02. In terms of profitability, ATR's ROE is +0.14%, compared to STSS's ROE of -1.54%. Regarding short-term risk, ATR is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for ATR.Check STSS's competition here
Daxor Corporation (NASDAQ: DXR)
ATR vs DXR Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, DXR has a market cap of 53M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while DXR trades at $9.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas DXR's P/E ratio is 7.37. In terms of profitability, ATR's ROE is +0.14%, compared to DXR's ROE of +0.13%. Regarding short-term risk, ATR is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for ATR.Check DXR's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
ATR vs OMIC Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas OMIC's P/E ratio is -0.58. In terms of profitability, ATR's ROE is +0.14%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, ATR is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for ATR.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
ATR vs IGAP Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas IGAP's P/E ratio is -10.52. In terms of profitability, ATR's ROE is +0.14%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, ATR is less volatile compared to IGAP. This indicates lower risk in terms of short-term price fluctuations for ATR.Check IGAP's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
ATR vs POCI Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, POCI has a market cap of 47.5M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while POCI trades at $4.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas POCI's P/E ratio is -9.41. In terms of profitability, ATR's ROE is +0.14%, compared to POCI's ROE of -0.24%. Regarding short-term risk, ATR is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for ATR.Check POCI's competition here
Nephros, Inc. (NASDAQ: NEPH)
ATR vs NEPH Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, NEPH has a market cap of 38.3M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while NEPH trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas NEPH's P/E ratio is 58.83. In terms of profitability, ATR's ROE is +0.14%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, ATR is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for ATR.Check NEPH's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
ATR vs HBIO Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, HBIO has a market cap of 37.5M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while HBIO trades at $8.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas HBIO's P/E ratio is -22.86. In terms of profitability, ATR's ROE is +0.14%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, ATR is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for ATR.Check HBIO's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
ATR vs SDC Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas SDC's P/E ratio is -0.03. In terms of profitability, ATR's ROE is +0.14%, compared to SDC's ROE of -1.96%. Regarding short-term risk, ATR is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for ATR.Check SDC's competition here
Milestone Scientific Inc. (AMEX: MLSS)
ATR vs MLSS Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, MLSS has a market cap of 27.3M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while MLSS trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas MLSS's P/E ratio is -6.02. In terms of profitability, ATR's ROE is +0.14%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, ATR is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for ATR.Check MLSS's competition here
Invacare Corporation (NYSE: IVC)
ATR vs IVC Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas IVC's P/E ratio is -0.79. In terms of profitability, ATR's ROE is +0.14%, compared to IVC's ROE of -0.46%. Regarding short-term risk, ATR is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for ATR.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
ATR vs RVP Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, RVP has a market cap of 17.4M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while RVP trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas RVP's P/E ratio is -4.84. In terms of profitability, ATR's ROE is +0.14%, compared to RVP's ROE of -0.05%. Regarding short-term risk, ATR is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for ATR.Check RVP's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
ATR vs ZJYL Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, ZJYL has a market cap of 16M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while ZJYL trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas ZJYL's P/E ratio is 14.02. In terms of profitability, ATR's ROE is +0.14%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, ATR is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for ATR.Check ZJYL's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
ATR vs BNGO Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, BNGO has a market cap of 13.3M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while BNGO trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas BNGO's P/E ratio is -0.37. In terms of profitability, ATR's ROE is +0.14%, compared to BNGO's ROE of -0.79%. Regarding short-term risk, ATR is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for ATR.Check BNGO's competition here
Femasys Inc. (NASDAQ: FEMY)
ATR vs FEMY Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, FEMY has a market cap of 12.6M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while FEMY trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas FEMY's P/E ratio is -0.33. In terms of profitability, ATR's ROE is +0.14%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, ATR is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for ATR.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
ATR vs RGNT Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, RGNT has a market cap of 9.2M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while RGNT trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas RGNT's P/E ratio is -0.53. In terms of profitability, ATR's ROE is +0.14%, compared to RGNT's ROE of N/A. Regarding short-term risk, ATR is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for ATR.Check RGNT's competition here
Lucyd, Inc (NASDAQ: LUCY)
ATR vs LUCY Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, LUCY has a market cap of 7.6M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while LUCY trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas LUCY's P/E ratio is -0.67. In terms of profitability, ATR's ROE is +0.14%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, ATR is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for ATR.Check LUCY's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
ATR vs CUPR Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, CUPR has a market cap of 5.1M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while CUPR trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas CUPR's P/E ratio is -1.37. In terms of profitability, ATR's ROE is +0.14%, compared to CUPR's ROE of -0.85%. Regarding short-term risk, ATR is less volatile compared to CUPR. This indicates lower risk in terms of short-term price fluctuations for ATR.Check CUPR's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
ATR vs NSTG Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas NSTG's P/E ratio is -0.03. In terms of profitability, ATR's ROE is +0.14%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, ATR is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for ATR.Check NSTG's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
ATR vs POAI Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas POAI's P/E ratio is -0.38. In terms of profitability, ATR's ROE is +0.14%, compared to POAI's ROE of -21.19%. Regarding short-term risk, ATR is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for ATR.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
ATR vs MHUA Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas MHUA's P/E ratio is 0.25. In terms of profitability, ATR's ROE is +0.14%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, ATR is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for ATR.Check MHUA's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
ATR vs GMVD Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas GMVD's P/E ratio is -0.01. In terms of profitability, ATR's ROE is +0.14%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, ATR is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for ATR.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
ATR vs GMVDW Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas GMVDW's P/E ratio is N/A. In terms of profitability, ATR's ROE is +0.14%, compared to GMVDW's ROE of +3.68%. Regarding short-term risk, ATR is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for ATR.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
ATR vs AVGR Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas AVGR's P/E ratio is -0.05. In terms of profitability, ATR's ROE is +0.14%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, ATR is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for ATR.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
ATR vs NXGLW Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, NXGLW has a market cap of 845.2K. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas NXGLW's P/E ratio is -0.02. In terms of profitability, ATR's ROE is +0.14%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, ATR is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for ATR.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
ATR vs LUCYW Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas LUCYW's P/E ratio is N/A. In terms of profitability, ATR's ROE is +0.14%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, ATR is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for ATR.Check LUCYW's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
ATR vs NXGL Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, NXGL has a market cap of 104.3K. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while NXGL trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas NXGL's P/E ratio is -7.03. In terms of profitability, ATR's ROE is +0.14%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, ATR is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for ATR.Check NXGL's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
ATR vs HRC Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, HRC has a market cap of 0. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas HRC's P/E ratio is 41.92. In terms of profitability, ATR's ROE is +0.14%, compared to HRC's ROE of +0.14%. Regarding short-term risk, ATR is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for ATR.Check HRC's competition here
Apria, Inc. (NASDAQ: APR)
ATR vs APR Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, APR has a market cap of 0. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas APR's P/E ratio is 22.59. In terms of profitability, ATR's ROE is +0.14%, compared to APR's ROE of +9.81%. Regarding short-term risk, ATR is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for ATR.Check APR's competition here
Analogic Corporation (NASDAQ: ALOG)
ATR vs ALOG Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas ALOG's P/E ratio is 40.93. In terms of profitability, ATR's ROE is +0.14%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, ATR is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for ATR.Check ALOG's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
ATR vs ATRS Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas ATRS's P/E ratio is 14.95. In terms of profitability, ATR's ROE is +0.14%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, ATR is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for ATR.Check ATRS's competition here
Invuity, Inc. (NASDAQ: IVTY)
ATR vs IVTY Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas IVTY's P/E ratio is -3.80. In terms of profitability, ATR's ROE is +0.14%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, ATR is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for ATR.Check IVTY's competition here
IntriCon Corporation (NASDAQ: IIN)
ATR vs IIN Comparison October 2026
AptarGroup, Inc. (NYSE: ATR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATR stands at 8B. In comparison, IIN has a market cap of 0. Regarding current trading prices, ATR is priced at $126.55 on the NYSE, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATR currently has a P/E ratio of 22.13, whereas IIN's P/E ratio is 226.45. In terms of profitability, ATR's ROE is +0.14%, compared to IIN's ROE of -0.00%. Regarding short-term risk, ATR is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for ATR.Check IIN's competition here